Previous Close | 20.88 |
Open | 20.98 |
Bid | 20.80 x 0 |
Ask | 21.00 x 0 |
Day's Range | 20.98 - 21.00 |
52 Week Range | 17.81 - 25.05 |
Volume | |
Avg. Volume | 8,551 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Great-West Lifeco will release its fourth quarter 2022 financial results after markets close on Wednesday, February 8, 2023.
Great-West Lifeco Inc. (the "Corporation") announced today that it has received approval from the Toronto Stock Exchange ("TSX") for the renewal of its Normal Course Issuer Bid ("NCIB").
Great-West Lifeco Inc. ("Lifeco") has been notified of an unsolicited mini-tender offer by Obatan LLC, made to residents of Ireland, to purchase up to 50,000 common shares of Lifeco. The unsolicited offer represents a discount of approximately 31.1% to the closing price of the common shares on the TSX on December 29, 2022, the last trading day before the offer was commenced. The common shares do not trade on a recognized stock exchange in Ireland.